0000950123-24-003271.txt : 20240412 0000950123-24-003271.hdr.sgml : 20240412 20240412162103 ACCESSION NUMBER: 0000950123-24-003271 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240412 DATE AS OF CHANGE: 20240412 EFFECTIVENESS DATE: 20240412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vida Ventures Advisors, LLC CENTRAL INDEX KEY: 0001831423 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20380 FILM NUMBER: 24841766 BUSINESS ADDRESS: STREET 1: 40 BROAD STREET STREET 2: SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 6176489100 MAIL ADDRESS: STREET 1: 40 BROAD STREET STREET 2: SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001831423 XXXXXXXX 03-31-2024 03-31-2024 false Vida Ventures Advisors, LLC

40 Broad Street Suite 201 Boston MA 02109

13F HOLDINGS REPORT 028-20380 N Jean-Philippe Kouakou-Zebouah 415-378-9984 /s/ Jean-Philippe Kouakou-Zebouah Boston MA 04-12-2024 0 5 180005410 false INFORMATION TABLE 2 31706.xml INFORMATION TABLE FOR FORM 13F Allogene Therapeutics, Inc. Common Stock 019770106 8037789 1798163 SH SOLE 1798163 0 0 Centessa Pharmaceuticals plc Ordinary Shares 152309100 44429544 3931818 SH SOLE 3931818 0 0 Dyne Therapeutics, Inc. Common Stock 26818M108 11568897 407499 SH SOLE 407499 0 0 Kronos Bio, Inc. Common Stock 50107A104 3594908 2765314 SH SOLE 2765314 0 0 Kyverna Therapeutics, Inc. Common Stock 501976104 112374272 4523924 SH SOLE 4523924 0 0